Pamidronatdinatrium Pfizer (Pamidronate Disodium)

Pamidronate Disodium, the active ingredient in Pamidronatdinatrium Pfizer, is a bisphosphonate presented as a unknown/unknown for intravenous use. It treats disorders of bone resorption such as hypercalcemia of malignancy, Paget's disease, and bone metastases in adult patients. GNH USA supplies Pamidronatdinatrium Pfizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Pamidronatdinatrium Pfizer as a licensed, GDP‑compliant international pharmaceutical supplier serving ... worldwide.

Pamidronate Disodium is used in the management of bone‑related conditions that involve excessive osteoclast activity.

- Hypercalcemia of malignancy: helps  reducing  the serum  calcium  level. - Paget's disease of bone: slows  the  abnormal  bone turnover  and  reduces  pain  and  lesion  size. - Bone metastases:  mitigates  skeletal  related  events  such  as  fracture  and  pain  by  inhibiting  oste  oste‑  activity. - Osteoporosis  :  reduces  fracture  risk  in  high  risk  patients  when  used  off‑  label  though  not  formally  approved  for  this     

       …  …  ...

   …